Table 2 Patient characteristics of urine samples used in the assessment of the UroMark assay
From: UroMark—a urinary biomarker assay for the detection of bladder cancer
Cohort 3 (N = 86) | Cohort 4 (N = 188) | |
|---|---|---|
Cancer | 52 | 55 |
Age | 62.4 (22–111) | 65.2 (36–90) |
Gender | ||
Male/Female | 49/13 | 43/12 |
Ta–T1 | 27 | 28 |
T2–T4 | 25 | 27 |
Low grade | 17 | 24 |
High grade | 35 | 31 |
Non-cancer | 34 | 133 |
Age | 62 (27–89) | 63 (29–144) |
Gender | ||
Male/Female | 20/14 | 82/51 |
Haematuria status | ||
Micro | 4 | 67 |
Macro | 11 | 51 |
Unknown | 19 | 15 |